Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 20.42% Profit Margin

May 30, 2025
REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) recently achieved the price target forecast set by QuantWave, the automated forecasting platform. The forecast signal was issued on April 1, 2025, with the stock trading at $615.16. The predicted direction was short, indicating a potential opportunity for profit. Fast forward to May 30, 2025, the stock reached the target price of $489.54, resulting in a profit margin of 20.42% for investors who followed the forecast.

This success highlights the accuracy and effectiveness of QuantWave's analytics in helping investors make informed decisions in the stock market. The achievement of the forecasted price target for REGENERON PHARMACEUTICALS, INC. showcases the platform's ability to provide valuable insights and profitable opportunities for its users.

In the broader market context, this forecast success for REGN demonstrates the importance of utilizing advanced data analytics and predictive tools in navigating the complexities of stock trading. With QuantWave's forecasting capabilities, investors can leverage accurate predictions to optimize their investment strategies and maximize returns.

QuantWave offers a wide range of stock forecasts, including REGENERON PHARMACEUTICALS, INC., providing users with diverse opportunities for potential profits. For those seeking to enhance their understanding of the investment process, QuantSchool offers comprehensive educational resources that delve into the professional investment framework behind QuantWave's analytics. By mastering the key principles outlined in QuantSchool, investors can unlock the full potential of the QuantWave forecasting system and achieve consistent income in the stock market.
If you want to leave a comment, then you need Login or Register





Other data for REGN

Related data

REGNJuly 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals  ~1 min.

Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....


REGNJune 27, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target  ~1 min.

Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin  ~1 min.

QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on December 13, 2024, predicted a short direction with a price of 728.18 $. On June 5, 2025, the stock reached the target price of 482....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the forecast price target set by QuantWave, resulting in a profit of 32.0%. The forecast signal was issued on December 31, 2024, with a price of $709....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. (REGN) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 27.18%....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 26.25%  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave on March 21, 2025. The forecast indicated a short direction, with the stock price at $657....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction  ~2 min.

REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. (ticker: REGN) has successfully achieved the price target forecast set by QuantWave, realizing a profit of 27.18%....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit  ~1 min.

On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at $674.49....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....


REGNMay 9, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target with 24.9% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully reached QuantWave's forecasted price target, resulting in a profit of 24.9%. The forecast signal was issued on February 27, 2025, with a price of 700....


REGNOctober 13, 2022REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 22.38% Profit: QuantWave's Success  ~2 min.

On August 4, 2022, QuantWave issued a long signal for REGENERON PHARMACEUTICALS, INC. with a price target of $749.35. The stock, which was at $612....


REGNAugust 13, 2024REGENERON PHARMACEUTICALS, INC. Hits 19.03% Profit Target as Forecasted by QuantWave  ~1 min.

On May 28, 2024, QuantWave's automated forecasting platform issued a long signal for REGENERON PHARMACEUTICALS, INC., with a price target of 1153.39 $....


REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Achieves Price Target Forecast with 18.25% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, with a profit of 18.25%....